PSP-001

N/A

Report date: 2025/03/11 14:45:26

Base Information

Drug NamePSP-001
Drug Alias NamePEGIFNλ-chimeraPEGINF-L chimeraPEGinterferon λ1-λ3 chimeraPSP001PSP-001 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterferon lambda receptor 1 modulators
TargetsInterferon lambda receptor 1
Therapy Area/IndicationsNorovirus InfectionsEnteritisHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesProsit Sole Biotechnology (Beijing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesProsit Sole Biotechnology (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsNorovirus InfectionsEnteritisHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A